ES2455440T3 - Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas - Google Patents

Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas Download PDF

Info

Publication number
ES2455440T3
ES2455440T3 ES10196249.6T ES10196249T ES2455440T3 ES 2455440 T3 ES2455440 T3 ES 2455440T3 ES 10196249 T ES10196249 T ES 10196249T ES 2455440 T3 ES2455440 T3 ES 2455440T3
Authority
ES
Spain
Prior art keywords
immunoglobulins
iga
antibody
light chains
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10196249.6T
Other languages
English (en)
Spanish (es)
Inventor
Arthur Bradwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Application granted granted Critical
Publication of ES2455440T3 publication Critical patent/ES2455440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES10196249.6T 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas Expired - Lifetime ES2455440T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
GB0501741 2005-01-27

Publications (1)

Publication Number Publication Date
ES2455440T3 true ES2455440T3 (es) 2014-04-15

Family

ID=34259791

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10196249.6T Expired - Lifetime ES2455440T3 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas
ES06703629.3T Active ES2365626T7 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES06703629.3T Active ES2365626T7 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas

Country Status (11)

Country Link
US (3) US7897353B2 (https=)
EP (2) EP1842071B3 (https=)
JP (3) JP5431674B2 (https=)
AT (1) ATE502302T1 (https=)
DE (1) DE602006020688D1 (https=)
DK (1) DK2306202T3 (https=)
ES (2) ES2455440T3 (https=)
GB (1) GB0501741D0 (https=)
PL (1) PL2306202T3 (https=)
PT (1) PT2306202E (https=)
WO (1) WO2006079816A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
WO2010120561A1 (en) 2009-04-01 2010-10-21 Genentech, Inc. Anti-fcrh5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) * 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
ES2702183T3 (es) * 2013-03-15 2019-02-27 Mayo Found Medical Education & Res Identificación y monitorización de inmunoglobulinas monoclonales por masa molecular
DE112014004109B4 (de) 2013-09-06 2021-05-20 Sensor Electronic Technology Inc. Diffuse Ultraviolettbeleuchtung
WO2015154052A1 (en) 2014-04-04 2015-10-08 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
GB201603291D0 (en) * 2016-02-25 2016-04-13 Binding Site Group The Ltd Antibodies
EP3681907A4 (en) 2017-09-13 2021-07-07 Mayo Foundation for Medical Education and Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS
WO2019055634A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
EP0044219A1 (en) 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
EP0862584B1 (en) * 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
EP1131344B1 (en) * 1998-11-19 2005-08-03 ELAN CORPORATION, Plc Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
US20040163137A1 (en) * 2001-02-20 2004-08-19 Caroline Barry PG-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
US20050154192A1 (en) * 2001-11-27 2005-07-14 Kamon Shirakawa Anti-il13 receptor alpha1 neutralizing antibody
US20040018576A1 (en) 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
CA2515699C (en) * 2003-02-10 2015-01-27 Aya Jakobovits Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
AU2004213053C1 (en) * 2003-02-20 2009-07-16 Seagen Inc. Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
EP1613658B1 (en) * 2003-04-02 2012-03-14 F. Hoffmann-La Roche AG Antibodies against insulin-like growth factor i receptor and uses thereof
WO2005062044A1 (ja) * 2003-11-19 2005-07-07 Yamasa Corporation ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
ATE502302T1 (de) 2011-04-15
US8592561B2 (en) 2013-11-26
JP2013147499A (ja) 2013-08-01
EP1842071A1 (en) 2007-10-10
EP1842071B3 (en) 2014-02-26
GB0501741D0 (en) 2005-03-02
WO2006079816A1 (en) 2006-08-03
JP2008528995A (ja) 2008-07-31
EP2306202A1 (en) 2011-04-06
DK2306202T3 (da) 2014-02-10
US20110177535A1 (en) 2011-07-21
US20080166742A1 (en) 2008-07-10
US8415110B2 (en) 2013-04-09
JP6007134B2 (ja) 2016-10-12
EP2306202B1 (en) 2013-12-18
EP1842071B1 (en) 2011-03-16
ES2365626T7 (es) 2014-06-04
PL2306202T3 (pl) 2014-05-30
PT2306202E (pt) 2014-02-27
ES2365626T3 (es) 2011-10-07
US20110177977A1 (en) 2011-07-21
US7897353B2 (en) 2011-03-01
JP2014025950A (ja) 2014-02-06
DE602006020688D1 (de) 2011-04-28
JP5431674B2 (ja) 2014-03-05
JP5715671B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
JP6007134B2 (ja) 免疫グロブリン重鎖−軽鎖対に特異的である単離抗体又はその断片
US20160341721A1 (en) Anti-human igm monoclonal antibody and immunoassay using the same
US20110312922A1 (en) EDTA Resistant S100A12 Complexes (ERAC)
KR101894597B1 (ko) 관절염 상태를 특성화하는 조성물 및 방법
CA2755486A1 (en) Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer
US20150285804A1 (en) Diagnostic method for colorectal cancer
US12474351B2 (en) Mass spectrometry calibrator
US11242408B2 (en) Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis
US20100248269A1 (en) Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer
CN107076760A (zh) 用于评估先兆子痫的生物标志物
JP7671956B2 (ja) 抗原の測定方法及び固相化抗体の製造方法
US20250264466A1 (en) Systems and methods for rheumatoid arthritis biomarker detection
CN118786347A (zh) 丝氨酸蛋白酶的检测用或测定用试剂
WO2017170847A1 (ja) 糖尿病の罹患を測定する方法
Leach et al. False reactivity in GTI Pak Plus® ELISA kits due to the presence of anti-mouse antibody in patients' samples
WO2022202876A1 (ja) Ｉ型コラーゲンｃ末端テロペプチドの免疫学的分析方法
JPH10307142A (ja) 抗ヘリコバクター・ピロリ抗体測定試薬及び該試薬を用いる測定方法